The 1840 Treaty of Waitangi between the British Crown and Maori chiefs was a landmark event in the history of New Zealand. Drafted in English, a Maori translation was prepared, ostensibly to ensure that Maori could have an accurate understanding of the terms. In retrospect, it is less clear that a meeting of the minds was intended:
The English and Māori texts differ. As some words in the English treaty did not translate directly into the written Māori language of the time, the Māori text is not a literal translation of the English text. It has been claimed that Henry Williams, the missionary entrusted with translating the treaty from English, was fluent in Māori and that far from being a poor translator he had in fact carefully crafted both versions to make each palatable to both parties without either noticing inherent contradictions.
“The covid vaccine is 95% effective” is a contemporary Treaty of Waitangi. The original is in the language of clinical trials. It was never translated. The public interpreted this phrase in their native language, normal English. What Pfizer said and what the public heard were quite different. The public would have been far more skeptical of these products had the clinical trial results been translated into normal English.
What we need is a proper translation and an explanation of how miscommunication happened.
The Injections Did Not Stop Infection
By now, everyone knows that the Pfizer and Moderna products did not stop people from getting Covid. Covid disease has mowed a wide strip through the double and triple-masked talking heads who told everyone that the shots would make them immune.
What is less well known is that:
- The products were never expected to stop infection or transmission.
- The clinical trials did not test for their ability to do so.
A clinical trial is designed to test a drug for effectiveness, which is strictly defined by one or more endpoints. An endpoint is a measurable outcome that can be assessed for each participant. With that in mind, prevention of infection was not an endpoint of the BioNTech/Pfizer injection clinical trials. And, this was known in 2020 before the products were approved for emergency use and distributed to the public starting in 2021.
In this New England Journal of Medicine research summary, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, under Limitations and Remaining Questions, we find that “whether the vaccine protects against asymptomatic infection and transmission to unvaccinated persons” remains unanswered by the clinical trial.
What did the clinical trial test for, if not the ability of the mRNA vaccine to stop transmission and/or infection? The trial was designed to test the ability of the injections to prevent “symptomatic Covid 19 cases” defined as one or more of a number symptoms and a positive test (see page 7 of the supplementary appendix for details).
@pfizer tweeted in Jan 2021 that stopping transmission was their “highest priority”. Their product does not do that, nor did the tweet make a claim that it did so. But it was their highest priority nonetheless. That, and getting as many people injected as possible.
Failure to Prevent Infection Was Known Before the Rollout
In October 2022, a Pfizer executive testified to an EU body that Pfizer had not tested the ability of the vaccine to stop transmission. This story was shocking to some and generated accusations that Pfizer had lied about the capabilities of the shots. But this information had been available since…
Read full story: The Vaccine Was “95% Effective” How? ⋆ Brownstone Institute